Clinical Trials Logo

15q Duplication Syndrome clinical trials

View clinical trials related to 15q Duplication Syndrome.

Filter by:
  • None
  • Page 1

NCT ID: NCT03694275 Completed - Clinical trials for CDKL5 Deficiency Disease

A Multicenter, Open-label, Pilot Study of Soticlestat (TAK-935/OV935) in Participants With 15Q Duplication Syndrome (Dup 15q) or Cyclin-Dependent Kinase-Like 5 (CDKL5) Deficiency Disorder (ARCADE STUDY)

Start date: September 10, 2018
Phase: Phase 2
Study type: Interventional

The purpose of this study is to investigate the effect of soticlestat on the frequency of motor seizures for participants with Dup15q or CDD during the Maintenance Period.